|
Designing patient versions of SIGN guidelines with service users |
3001 |
|
Conflict of interest disclosure and management in Japanese clinical practice guidelines |
3002 |
|
Involving patients in the development of clinical practice guidelines in Kazakhstan |
3003 |
|
Public and patient involvement in the HTA decision-making process in Kazakhstan |
3004 |
|
Integrating guidelines and evaluations: The Swedish model for improving adherence to national guidelines on multiple sclerosis |
3005 |
|
Integrating guidelines and evaluations: The Swedish model for improving adherence to national guidelines in Parkinson’s Disease |
3006 |
|
Priority setting in the Swedish stroke guidelines |
3007 |
|
Adapting national to international guidelines and back – an example on groin hernia guidelines |
3008 |
|
Using reference manager (Mendeley) in systematic reviews |
3010 |
|
PATH’s 10-Part Advocacy Strategy Development: A tool for evidence building and use in engagement with policy makers in Uganda |
3011 |
|
Stakeholder analysis for advancing health-technology assessment in India: A pilot |
3012 |
|
Effectiveness of Problem-Based-eLearning (e-PBL) for pre- and post-registration health professional education |
3013 |
|
Virtual reality environments (VRE) for pre-and post- registration health professional education |
3014 |
|
Harmonising clinical practice guidelines and shared decision making |
3015 |
|
Individual effects for well-informed shared decision making for atrial fibrillation thromboembolic prophylaxis: WISDM for A FIB |
3016 |
|
A south-to-south collaboration: Localising a global health innovation - the PACK Brazil case study |
3017 |
|
Improving the quality of clinical practice guidelines in Peru |
3018 |
|
Combining evidence from observational and modelling studies to inform a breast cancer screening guideline |
3019 |
|
Editing podcast scripts for local reality |
3020 |
|
Parenteral glutamine supplementation in critically ill adults: An approach to support evidence-informed decision making by a national Essential Medicines List (EML) Expert Committee |
3021 |
|
Strategic Advisory Group of Experts on Immunization (SAGE) |
3022 |
|
Review of quality-assessment tools in systematic reviews of cost-effectiveness analyses. Are checklists fit for purpose? |
3023 |
|
Exploring the type of graphical representation of results from network meta-analysis that different stakeholders would prefer. An Italian survey |
3024 |
|
Evidence Aid Zika Collection |
3025 |
|
An evaluation of the EBM Guidelines database by French GPs |
3026 |
|
Synopses of national and international guidelines as the basis for disease-management programmes |
3027 |
|
Using a hospital evidence-based practice centre (EPC) to inform nursing policy and practice: Describing an approach |
3028 |
|
Systematic appraisal of Chilean clinical guidelines included in the 'Explicit Guarantees in Healthcare' Program using AGREE II |
3029 |
|
A flexible online tool for the management of complex evidence-synthesis projects |
3030 |
|
State-society relations in low-and middle-income countries: An evidence-gap map |
3031 |
|
What are the characteristics of clinical practice guidelines for the treatment of depression? |
3032 |
|
Assessment of the reporting quality of clinical practice guidelines using CheckUP list/tool |
3033 |
|
Evidence based toolkits for enabling evidence use |
3034 |
|
Evidence-informed decision making in achieving universal health coverage: The role of the Evidence Informed Network (EVIP-Net) in Africa |
3035 |
|
Developing evidence-based guidelines for infectious and neglected tropical diseases in Brazil |
3036 |
|
Developing a published evidence map as a tool to identify and prioritise intervention types in Type-2 Diabetes management |
3037 |
|
The evidence base is one part of the story when developing clinical guidelines |
3038 |
|
Tools for sharing evidence for effectiveness from a systematic review of complex interventions to improve food security: Which do policy makers prefer? |
3039 |
|
Accelerated developed guideline (ADG) on cardiovascular risk prevention and dyslipidaemias management |
3040 |
|
Therapeutic Guidelines Developing Countries Programme |
3041 |
|
Impact of cut-offs on guideline synopses for the preparation of disease-management programmes |
3042 |
|
Development of a clinical guideline about postmortem radiology, including the perspective of relatives and development of a network |
3043 |
|
The Malnutrition in the Elderly (MaNuEL) Knowledge Hub: Tackling the increasing problem of malnutrition in older persons |
3044 |
|
Network meta-analyses in clinical guideline development for cutaneous Lyme borreliosis |
3045 |
|
Two-year follow up in a breast-screening decision aid RCT: Retention of overdetection knowledge and other decision-making effects |
3046 |
|
Validation of a questionnaire to measure people’s ability to assess claims about treatment effects in Spanish |
3047 |
|
Reporting of updating process in updated clinical guidelines: A systematic assessment |
3048 |
|
Systematic review of research using insurance claim data in Korea |
3049 |
|
Preclinical requirements in 114 EMA and 120 FDA therapeutic area guidelines: Helpful for trialists, evaluators, and meta-research? |
3050 |
|
Re use of extracted data – an ontology-based approach |
3051 |
|
Taking the informative value into account; the FIT-tool for a priori determination of the informative value of evidence |
3052 |
|
Streamlining communication of Cochrane content between three German language Cochrane entities under an international umbrella |
3053 |
|
Automating RCT identification can identify more than 99% of RCTs included in Cochrane reviews and could reduce manual screening by 77% |
3054 |
|
The Human Behaviour-Change Project: Collaborating with computer and information scientists to improve behavioural science |
3055 |
|
Developing service delivery guidelines on acute medical emergencies: Challenges and solutions |
3056 |
|
Social media strategy for disseminating systematic review evidence |
3057 |
|
Development of a transparent proposal process for guidelines focused on uncertainties in clinical care |
3058 |
|
Guidelines for rare diseases: Why are they so difficult to develop? |
3059 |
|
Exploration of barriers, facilitators and users’ experiences of the GRADE-DECIDE Interactive Evidence to Decision framework (iEtD) |
3060 |
|
Using Evidence to nurture multi-actor dialogue in the public sector: Lessons from the Paliament of Uganda |
3061 |
|
Construction of a clinical pathway development working group |
3062 |
|
The methodological quality of clinical pathways published in journals in China: 2014-2016 |
3063 |
|
The reporting quality of clinical guidelines in China based on Reporting Items for Practice Guidelines in Healthcare (RIGHT) |
3064 |
|
Research networks, are they worth the effort? Experiences of establishing and running an evidence-synthesis network in northwest England |
3065 |
|
Using evaluations as learning and programme-improvement tools – Lessons from Uganda |
3066 |
|
A comparison of different approaches for editing health-related information: An editor's satisfaction perspective |
3067 |
|
Sharing resources to develop a guideline with little direct cost: the Bahrain Evidence-based Guideline INitiative (B.E.G-I-N) experience |
3068 |
|
Develop accelerated guidelines, based on a selective literature search |
3069 |
|
Deciding when a guideline will stand the test of time – the use of a static list |
3070 |
|
The updating of clinical practice guidelines in China |
3071 |
|
Who is responsible for developing patient guidelines? |
3072 |
|
A database of systematic reviews in eyes and vision – a cross-section of the evidence available to underpin clinical practice guidelines and set the research agenda |
3073 |
|
Balancing risks, harms and benefits in guideline development for pain management |
3074 |
|
Effectiveness of audiovisual formats as strategies for knowledge translation in health: A systematic review of literature |
3075 |
|
Evidence-based design of 12 knowledge clips in maternal and neonatal health |
3076 |
|
Landmark change in Australian cervical screening practice: Clinical guidelines to make a great public-health programme even better |
3077 |
|
The application of traditional Chinese medicine (TCM) and acupuncture in assisted reproductive technology (ART): Evidence mapping |
3078 |
|
Assessment of Russian clinical practice guidelines with the AGREE II instrument |
3079 |
|
Guideline use behaviours and needs of primary-care practitioners in China: A cross-sectional survey |
3080 |
|
Establishing the prevalence of low back pain in Africa: Methodological issues in putting it all together |
3081 |
|
Evaluation of network meta-analysis in clinical practice guidelines for percutaneous coronary intervention: A systematic review |
3082 |
|
A review of the quality of tuberculosis costing studies |
3083 |
|
Brazilian guideline for diagnosis and treatment of Chagas disease |
3084 |
|
Disclosure and management of conflicts of interests in clinical practice guidelines |
3085 |
|
Implementing a school vision screening programme using smartphone technology in southern Botswana |
3086 |
|
Using evidence to improve lives: A rapid systematic approach |
3087 |
|
Plain language summaries as tools for raising awareness of Cochrane evidence and social media as dissemination channels in Poland |
3088 |
|
An evidence-based novelty model for the incorporation of evidence in pharmaceutical policy |
3089 |
|
Developing the evidence-base Clinical Practice Guideline of Retinopathy of prematurity for Latin-American: An effort of PAHO, Cochrane STI and GIN Iberoamerican. |
3090 |
|
Infection prevention in general practice, the challenge of developing a guideline |
3091 |
|
Cost and performance accounting as a base for modeling update options. Data from the German Guideline Program in Oncology |
3092 |
|
Guideline on multimorbidity of the German College of General Practitioners and Family Physicians (DEGAM) |
3093 |
|
Social media as a knowledge-translation tool to disseminate public-health evidence |
3094 |
|
An evaluation of emergency guidelines issued by WHO in response to the 2015-16 Zika virus outbreak |
3095 |
|
Cochrane workshop: Product marketing and management |
3096 |
|
Cost-effectiveness of empirical prescribing of antimicrobials in community-acquired pneumonia in Colombia |
3097 |
|
The development of evidence-based resources for cancer care |
3098 |
|
Developing clinical practice guidelines for low-to-middle income countries: Methods, experiences and lesson learnt in adapting, adopting or contextualising existing CPGs |
3099 |
|
Low-cost, high-quality guidelines through global partnership working |
3100 |
|
Quality and feasibility of guideline adaptation by general practice trainees |
3101 |
|
What's unique about conducting research with adolescents in low- and middle-income countries: Introducing a new methodological series |
3102 |
|
Building awareness for evidence-based practice in Malaysia |
3103 |
|
Development of medical and tecnhological documents on standardisation of medical care in cardiovascular diseases in Ukraine |
3104 |
|
Cost-effectiveness of cardiac rehabilitation versus usual care in Chile |
3105 |
|
How to optimise the implementation of a computerised decision-support tool for knee osteoarthritis in Belgian general practice? |
3106 |
|
Standards for Reporting of Overviews of Reviews and Umbrella Reviews (STROVI) statement |
3107 |
|
International Guidelines: Adapt to local clinical practice or not? |
3108 |
|
Presidential hotline: A potential tool for evidence-based decision making in the health sector in South Africa |
3109 |
|
How evidence-based is online information for patients? Analysis of orthodontic websites for accuracy of content compared to systematic review findings |
3110 |
|
Updating national guidelines with recommendations of duration of sickness absence and as a tool for assessing work ability |
3111 |
|
Outcomes-Based Education (OBE) Model for Nursing Colleges: An ASEAN Integration Initiative of Philippine Schools of Nursing |
3112 |
|
Matching guideline questions to Cochrane Review questions – a linked data test case |
3113 |
|
World Health Organization mental health gap action programme (mhGAP) intervention guide: A review of evidence from low- and middle-income countries |
3114 |
|
Transferring evidence into practice: A Nursing Minimum Data Set within the nutritional area in primary healthcare |
3115 |
|
Making evidence short, shareable and social |
3116 |
|
Adapting foreign guidelines on post-stroke dysphagia identification and management to local context in China |
3117 |
|
The effectiveness of low-power laser therapy for fibromyalgia: A systematic review |
3118 |
|
Development of a critical-appraisal tool for hospital clinical practice guideline in Cipto Mangunkusumo General Hospital, Indonesia |
3119 |
|
Evidence Maps: A tool for stakeholder-engaged health-policy development |
3120 |
|
Testicular cancer - methodological quality of clinical guidelines and systematic reviews |
3121 |
|
Project Transform: Supporting Australian guideline developers to access and use research evidence |
3122 |
|
Updating the National Disease Management Guideline for Non-specific Chronic Low Back Pain – a best-practice example |
3123 |
|
Wikipedia: An important dissemination tool for Cochrane |
3124 |
|
Encyclopaedia of clinical guidelines in South Africa – A mapping project |
3125 |
|
Impact of point-of-care diagnostics on maternal outcomes in HIV-infected women: Systematic review and meta-analysis |
3126 |
|
Use of Cochrane reviews in guidelines for general practitioners |
3127 |
|
Methodological tasks of clinical practice guidelines developed in Japan |
3128 |
|
Systematic review of clinical practice guidelines in the diagnosis and management of ST-elevation myocardial infarction |
3129 |
|
Selecting tools to assist general practitioners in the diagnosis and assessment of severity of work-related mental health conditions |
3130 |
|
Describing a user-centred approach to developing key clinical questions for guidelines for general practitioners |
3131 |
|
Reviewing systematic reviews: Can technology boost children’s learning? A meta-analysis of What Works Clearinghouse (WWC) early childhood education programmes |
3132 |
|
Adverse effects reviews of opioids - a key element for balanced systematic reviews and guidelines |
3133 |
|
Impact of a guideline update on recommendations and didactic material: The example of AFAM (African First Aid Materials) |
3134 |
|
From populations to people - how NICE guidelines support shared decision making |
3135 |
|
Development of an evidence- and narrative-based patient decision aid for secondary prevention of myocardial infarction |
3136 |
|
Analysis of publication characteristics for Campbell systematic reviews |
3137 |
|
A systematic review and meta-analysis: The effectiveness of animal-assisted interventions for common mental disease |
3138 |
|
Can we make patient versions of guidelines more applicable to patients and the public? |
3139 |
|
The analysis of appraisal of Chinese clinical practice guidelines |
3140 |
|
Disseminating Cochrane evidence with the leading social media on mobile phones in China |
3141 |
|
Assessing the optimal presentation of how patients value health outcomes (values and preferences): A qualitative user testing |
3142 |
|
Challenges and inspirations in disseminating clinical evidence on Traditional Chinese Medicine: 10 years' experiences from volunteers |
3143 |
|
Recognising delirium in hospitalised children: A systematic review of risk factors and characteristics of acute paediatric delirium |
3144 |
|
Reducing labour and time in creating a systematic review for Japanese rehabilitation nutrition guideline by using artificial intelligence and social networks |
3145 |
|
User preferences regarding online tools for systematic review and guideline production: Results from a G-I-N Tech Survey |
3146 |
|
A best-practice implementation project of the maintenance of totally implantable ports: Lessons from one high-volume centre |
3147 |
|
Perceived program impact of a combined skilful parenting and economic strengthening intervention on parent-child interaction and child maltreatment: Implications for understanding processes of change in parenting interventions |
3148 |
|
Perceptions and experiences of participant recruitment to trials: A qualitative interview study with trial stakeholders |
3149 |